HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Perilipin 5 promotes hepatic steatosis in dairy cows through increasing lipid synthesis and decreasing very low density lipoprotein assembly.

Abstract
Fatty liver is a common metabolic disorder in dairy cows during the transition period. Perilipin 5 (PLIN5), a lipid droplet coat protein, plays important roles in the development of hepatic steatosis in mice and humans. Whether PLIN5 plays a role in the development of fatty liver in dairy cows is unknown. An in vivo study consisting of 10 healthy and 10 cows with fatty liver was performed to harvest liver tissue and blood samples. In addition, hepatocytes isolated from calves were infected with PLIN5 overexpression adenovirus for 48 h; treated with 0, 0.6, 1.2, or 2.4 mM nonesterified fatty acids (NEFA) for 24 h; or infected with PLIN5 silencing adenovirus for 48 h and then treated with 1.2 mM NEFA for 24 h. Serum concentrations of NEFA and β-hydroxybutyrate were greater in cows with fatty liver. Milk production and plasma glucose concentrations were lower in cows with fatty liver. The results revealed that PLIN5 is highly expressed in steatotic liver and localized to lipid droplets. The abundance of fatty acid and triacylglycerol (TAG) synthesis-related proteins including sterol regulatory element binding protein-1c, fatty acid synthase, acetyl-coA carboxylase 1, diacylglycerol acyltransferase 1, and diacylglycerol acyltransferase 2 was greater in the liver of cows with fatty liver. In contrast, the abundance of microsomal triglyceride transfer protein (MTP), apolipoprotein B100, and apolipoprotein E was lower in the liver of cows with fatty liver. Consequently, cows with fatty liver exhibited severe hepatic TAG accumulation and lower blood concentration of very low density lipoprotein apolipoprotein B (VLDL-ApoB). Overexpression of PLIN5 and exogenous NEFA in cultured hepatocytes increased the abundance of sterol regulatory element binding protein-1, fatty acid synthase, acetyl-coA carboxylase 1, diacylglycerol acyltransferase 1, and diacylglycerol acyltransferase 2 but decreased the abundance of microsomal triglyceride transfer protein, apolipoprotein B100, and apolipoprotein E, which promoted TAG synthesis and inhibited VLDL-ApoB assembly, inducing lipid accumulation. Importantly, knockdown of PLIN5 attenuated the upregulation of TAG synthesis and downregulation of VLDL-ApoB assembly induced by NEFA. Overall, these data suggest that NEFA activate PLIN5, leading to TAG accumulation and inhibition of VLDL assembly. As such, these mechanisms explain in part the development of hepatic steatosis in dairy cows.
AuthorsHongdou Jia, Xiaobing Li, Guowen Liu, Juan J Loor, Ryan Bucktrout, Xudong Sun, Guojin Li, Xin Shu, Jihong Dong, Yazhe Wang, Rankun Zuo, Zhe Wang, Xinwei Li
JournalJournal of dairy science (J Dairy Sci) Vol. 102 Issue 1 Pg. 833-845 (Jan 2019) ISSN: 1525-3198 [Electronic] United States
PMID30415861 (Publication Type: Journal Article)
CopyrightCopyright © 2019 American Dairy Science Association. Published by Elsevier Inc. All rights reserved.
Chemical References
  • Apolipoprotein B-100
  • Apolipoproteins E
  • Carrier Proteins
  • Fatty Acids
  • Fatty Acids, Nonesterified
  • Lipids
  • Lipoproteins, VLDL
  • Perilipin-5
  • Sterol Regulatory Element Binding Protein 1
  • Triglycerides
  • microsomal triglyceride transfer protein
  • Diacylglycerol O-Acyltransferase
  • 3-Hydroxybutyric Acid
Topics
  • 3-Hydroxybutyric Acid (blood)
  • Animals
  • Apolipoprotein B-100 (metabolism)
  • Apolipoproteins E (metabolism)
  • Carrier Proteins (metabolism)
  • Cattle
  • Cattle Diseases (blood, genetics, metabolism)
  • Diacylglycerol O-Acyltransferase (metabolism)
  • Fatty Acids (metabolism)
  • Fatty Acids, Nonesterified (blood)
  • Fatty Liver (blood, genetics, metabolism, veterinary)
  • Female
  • Lipid Droplets (metabolism)
  • Lipids (biosynthesis)
  • Lipoproteins, VLDL (metabolism)
  • Liver (metabolism)
  • Mice
  • Perilipin-5 (genetics, metabolism)
  • Sterol Regulatory Element Binding Protein 1 (genetics, metabolism)
  • Triglycerides (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: